Search Results
May 12, 2026, 07:05 ET Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
statistically significant weight loss from baseline, and the full dataset presented at ECO provides a detailed picture of response over time," said Brian Lian, Ph.D., chief executive officer of Viking Therapeutics. "We are excited to move oral VK2735 into Phase 3 development as we believe it has the potential
More news about: Viking Therapeutics, Inc.
Apr 29, 2026, 16:05 ET Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
excited to report that the advances and strong momentum Viking created in 2025 have carried forward through the first quarter of 2026," stated Brian Lian, Ph.D., chief executive officer of Viking. "Looking ahead, we continue to execute the Phase 3 clinical development program for our lead obesity program
More news about: Viking Therapeutics, Inc.
Apr 15, 2026, 09:00 ET NVTC Spotlights Region's AI Trailblazers: Meet the 2026 AI50
Harrison, Acentra Health Dinakar Hituvalli, Deltek Michael Jenkins, Knowmadics Gerald Kierce, Trustible Hahna Latonick, Dark Wolf KJ Lian, AWS Dave Link, ScienceLogic Murali Mallina, Tria Federal Eamon McCormick, Red Hat Luther McGinty, CATHEXIS Mike Pansky,
More news about: Northern Virginia Technology Council
Apr 09, 2026, 18:24 ET Lightwheel and PeritasAI Announce Strategic Partnership to Bring Physical AI into Perioperative Workflows
on patient care.""Physical AI will only create real value when it can operate reliably in the world's most complex environments," said Louis Lian, VP of Partnerships and Strategy at Lightwheel. "Healthcare is one of the hardest, and this partnership reflects a shared belief that real deployment
More news about: Lightwheel Limited
Mar 26, 2026, 07:05 ET Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
in the VANQUISH-2 study is an important milestone for Viking as it is the second of our two registration studies to be fully enrolled," said Brian Lian, Ph.D., chief executive officer of Viking. "As with the VANQUISH-1 study, we are happy to see a study of this size enroll quickly, which we believe speaks
More news about: Viking Therapeutics, Inc.
Mar 23, 2026, 08:30 ET Eco Wave Power Advances Taiwan Expansion as Partner Signs Land Lease for Suao Port Wave Energy Project
The Company's Taiwanese partner, I-Ke International Ocean Energy Co. ("I-Ke"), a subsidiary of Lian Tat Company, informed Eco Wave Power that in December 2025 it signed the land lease agreement with Suao Port for the designated wave energy project
More news about: Eco Wave Power Global AB (publ)
Mar 19, 2026, 20:00 ET Taiwan hosts APEC Workshop Highlights Innovative Technologies for Low-Carbon Food Supply Chains
JIANN has implemented heat recovery and smart control systems in sterilization processes to enhance energy efficiency while maintaining product quality. Lian-Hwa Foods has introduced green products manufactured through advanced, efficient, low-carbon smart production lines. Companies such as VIGOR DONG SHIH
More news about: Food Industry Research and Development Institute (FIRDI)
Mar 05, 2026, 22:35 ET Professional managers key to rural vitalization, expert says
governance, a national political adviser said, arguing the move will help unlock sustainable growth in the countryside.The proposal from Zhou Li'an, a member of the National Committee of the Chinese People's Political Consultative Conference and an expert on rural economy and regional development,
More news about: chinadaily.com.cn
Feb 13, 2026, 11:26 ET Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
VANQUISH-2 nears full enrollment."The past year was an exceptional year for Viking marked by rapid progress across our obesity portfolio," said Brian Lian, Ph.D., CEO of Viking Therapeutics. "We also expect to file an IND for our novel amylin agonist this quarter, expanding our obesity franchise."Viking
More news about: Equity Insider
Feb 12, 2026, 03:39 ET "Spring Begins Anew • Galloping Miles Ahead", Chinese Spring Festival Cultural Exhibition Successfully Held in Addis Ababa, Ethiopia
to view staged excerpts of Wu Opera and digital presentations of traditional customs such as dragon dances, Da Tie Hua (molten iron fireworks), and Lian Huo (ritual fire-walking). Public workshops and performance segments were incorporated into the program. Calligraphy practitioners provided guided
More news about: Zhejiang Provincial Department of Culture, Radio, Television and Tourism
Feb 11, 2026, 16:16 ET Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Other Recent Events:"The past year was an exceptional year for Viking marked by rapid progress across our obesity portfolio," stated Brian Lian, Ph.D., chief executive officer of Viking. "In June, the company initiated the Phase 3 VANQUISH clinical program evaluating the subcutaneous formulation
More news about: Viking Therapeutics, Inc.
Feb 04, 2026, 10:07 ET 美國郵政署發佈最新農曆新年郵票
Gary Poon、侯斯頓西南管理區董事會主席 Kenneth Li 以及歌劇藝術家 Lian Chen Walker。亞太裔美國人傳統協會董事會主席
More news about: U.S. Postal Service
Feb 03, 2026, 12:00 ET USPS Unveils Latest Lunar New Year Stamp
Gary Poon, CEO of the Chinese Community Center; Kenneth Li, board chair of Houston's Southwest Management District; and opera artist Lian Chen Walker.Asian Pacific American Heritage Association Board of Directors President
More news about: U.S. Postal Service
Jan 21, 2026, 10:09 ET Mindgruve Accelerates European Growth with Acquisition of Ameo
recent hire of former Amazon executive Spencer Lian-Thornton, reflecting the company's continued investment in its retail media and commerce offering. To learn more about Mindgruve's commerce, retail
More news about: Mindgruve
Jan 12, 2026, 07:00 ET Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity
best-in-class dual GLP-1/GIP agonist and were central to our designing of the ongoing VANQUISH Phase 3 program for VK2735," said Brian Lian Ph.D., chief executive officer of Viking. "The response among patients and clinicians for the VANQUISH studies has been positive, with VANQUISH-1 over-enrolled
More news about: Viking Therapeutics, Inc.
Jan 08, 2026, 07:00 ET Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
health benefits from weight loss and may provide an opportunity to further differentiate VK2735 from currently available obesity treatments," said Brian Lian Ph.D., chief executive officer of Viking. "Importantly, the same dual-acting GLP-1/GIP agonist molecule is used in both our subcutaneous
More news about: Viking Therapeutics, Inc.
Jan 07, 2026, 07:00 ET Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
for VK2735, including engagement with potential strategic partners, representing a key step in our preparation for commercial success," said Brian Lian, Ph.D., chief executive officer of Viking.Prior to joining Viking, Mr. Aubuchon was the chief commercial officer at AbCellera, where he was responsible
More news about: Viking Therapeutics, Inc.
Jan 05, 2026, 16:03 ET Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January
More news about: Viking Therapeutics, Inc.
Jan 05, 2026, 08:11 ET Mindgruve Appoints Spencer Lian-Thornton as VP of Growth and Partnerships
Spencer Lian-Thornton as Vice President of Growth and Partnerships, effective January 2, 2026. Lian-Thornton will play a key role in accelerating Mindgruve's growth, deepening enterprise partnerships,
More news about: Mindgruve
Dec 31, 2025, 08:07 ET The End of Shots? 5 Biotech Stocks Rethinking Diabetes
change in body weight from baseline at 78 weeks."We are excited to announce completion of enrollment in VANQUISH-1 ahead of schedule," said Brian Lian, Ph.D., CEO of Viking. "As with prior VK2735 studies, the trial accrued rapidly and exceeded our enrollment target. We believe this speaks to
More news about: USA News Group
Dec 22, 2025, 20:18 ET THE KYLN HOTEL SUZHOU CELEBRATES GRAND OPENING, JOINING THE JDV BY HYATT BRAND
noodle dishes, Suzhou-style dim sum, and tea-infused cocktails in a lively setting, daily. Open daily for breakfast and all-day à la carte dining, Cai Lian 1090 utilizes premium, seasonal ingredients in its wide selection of Chinese and international dishes, served in a design-forward space inspired
More news about: KYLN Hotel Suzhou, part of JdV by Hyatt
Nov 19, 2025, 02:55 ET Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735
the primary dosing period. "We are excited to announce completion of enrollment in VANQUISH-1 ahead of schedule," said Brian Lian, Ph.D., chief executive officer of Viking. "As with prior VK2735 studies, the trial accrued rapidly and exceeded our enrollment target. We believe
More news about: Viking Therapeutics, Inc.
Nov 17, 2025, 08:00 ET Shipday Closes $7 Million Series A, Led by ECP Growth and Ibex Investors, to Empower Small and Medium-Sized Businesses with AI-Powered Last-Mile Delivery Solutions
Heather MilkeJoele Frank, Wilkinson Brimmer Katcher212-355-4449 Ibex InvestorsLian [email protected]+972-50-2846262
More news about: Shipday
Nov 15, 2025, 22:36 ET Xinhua Silk Road -- Китайский Blanc de Chine -- десятилетия наследия и глобального охвата
Сегодня в Dehua работают более 6 000 профессиональных художников-керамистов. Среди них мастер своего дела — художник Лиан Дели (Lian Deli), чья работа в традиционном стиле «Миф» изготовлена из ультратонкого фарфора толщиной всего 0,2 миллиметра — эталон искусства тонкостенного фарфора
More news about: Xinhua Silk Road
Nov 14, 2025, 14:55 ET Xinhua Silk Road: Blanc de Chine: desaťročie čínskeho dedičstva a globálneho dosahu
vytvoril silnú zásobu talentov. Dnes má Dehua viac ako 6000 profesionálnych keramických umelcov. Jedným z nich je aj majster umelec Lian Deli, ktorého reprezentatívne dielo Mýtus predstavuje ultratenký porcelán s hrúbkou len 0,2 milimetra – čo je štandard v remesle výroby tenkého porcelánu
More news about: Xinhua Silk Road